E.YU. AKULINUSHKINA¹, E.I. APEKISHEVA, S.P. YAKUPOVA², R.Z. ABDRAKIPOV², E.S. ZAMANOVA²

 ¹Kazan State Medical University, Kazan

²Republic Clinical Hospital of the MH RT, Kazan

 Contact details:

Akulinushkina E.Yu. — resident physician on rheumatology of the Department of Hospital Therapy

Address: 49 Butlerov St., Kazan, Russian Federation, 420012, tel.: +7-999-228-37-92, e-mail: katewenterly@gmail.com

Most of the systemic connective tissue diseases affect the respiratory system, most often — lung tissue, but due to the worldwide spread of the new coronavirus, lung lesions are often explained as this disease. It dictates the need to distinguish pulmonary lesion in COVID-19 and other pathological conditions of the lungs, despite similar clinical, laboratory and instrumental signs. A complex differential diagnosis of the etiological origin of lung lesion was carried out in patients with rheumatic diseases after the new coronavirus infection, which is very important during the SARS-Cov-2 pandemic due to the presence of opposite therapeutic tactics — increase or decrease of cytostatic treatment. The symptomatology and the course of lung disease are the most important for the differential diagnosis of these conditions, and computed tomography is the most important instrumental method of examination. Further study and clinical observation is needed.

Key words: COVID-19, lung lesion, pneumonia.

REFERENCES

1. Bestaev D.V., Karateev D.E., Nasonov E.L. Lung damage in rheumatoid arthritis. Nauchno-prakticheskaya revmatologiya, 2014, no. 52 (4), pp. 451–457 (in Russ.).
2. Moiseev S.V., Novikov P.I., Chebotareva N.V. et al. Extra-articular (systemic) manifestations of rheumatoid arthritis. Klinicheskaya farmakologiya i terapiya, 2020, no. 29 (1), pp. 53–60 (in Russ.).
3. Salaffi F., Carotti M., Di Carlo M., Tardella M., Giovagnoni A. High-resolution computed tomography of the lung in patients with rheumatoid arthritis: Prevalence of interstitial lung disease involvement and determinants of abnormalities. Medicine (Baltimore), 2019, vol. 98 (38).
4. Anan’eva L.P. Diagnostics and treatment of interstitial lung lesions in systemic scleroderma. Sovremennaya revmatologiya, 2018, no. 12 (2), pp. 12–21 (in Russ.).
5. Voytsekhovskiy V.V., Goborov N.D., Pogrebnaya M.V. Lung damage in systemic scleroderma. Byulleten’ fiziologii i patologii dykhaniya, 2018, vol. 1, no. 70 (in Russ.).
6. Hannah Jennifer R., D’Cruz David P. Pulmonary Complications of Systemic Lupus Erythematosus. Seminars in respiratory and critical care medicine, 2019, vol. 40 (2), pp. 227–234.
7. Klyukvina N.G., Aseeva E.A., Nikonorova N.O. Lung damage in systemic lupus erythematosus: well-known facts and unresolved issues. Nauchno-prakticheskaya revmatologiya, 2016, no. 54 (5), pp. 578–589.
8. Antelava O.A., Bondarenko I.B., Chichasova N.V., Nasonov E.L. Respiratory disorders in polymyositis/dermatomyositis. Sovremennaya revmatologiya, 2014, no. 1, pp. 31–38.
9. Vivino F.B. Sjogren’s syndrome: Clinical aspects. Clinical Immunology (Orlando, Fla.), 2017, vol. 182, pp. 48–54.
10. Augustine S. Lee, MD R. Hal Scofield, MD Katherine Morland Hammitt et al. Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjögren’s. October 15, 2020. DOI: 10.1016/j.chest.2020.10.011
11. Rossiyskie klinicheskie rekomendatsii. Revmatologiya, pod red. E.L. Nasonova [Russian clinical guidelines. Rheumatology, ed. by E.L. Nasonov]. Moscow: GEOTAR-Media, 2017. Pp. 182–206.
12. Beketova T.V. Kogan’s syndrome is a new nosology in the modern classification of systemic vasculitis. Clinical observation and literature review. Nauchno-prakticheskaya revmatologiya, 2016, no. 54 (4), pp. 463–468 (in Russ.).
13. Anaev E.Kh. Pulmonary vasculitis: differential diagnosis. Prakticheskaya pul’monologiya, 2017, no. 1, pp. 51–57.
14. Trofimova T.N., Lukina O.V., Speranskaya A.A., Il’ina N.A., Gavrilov P.V., Panuntseva K.K. Lektsiya: Koronavirusnaya infektsiya COVID-19. Ch. 5. Luchevye metody issledovaniya pri COVID-19 i virusnykh pnevmoniyakh [Lecture: Coronavirus infection COVID-19. Part 5. Radiation research methods for COVID-19 and viral pneumonia], available at: https://www.1spbgmu.ru/images/home/covid19/obuchenie_vrachey/Chast’_5_Luchevaya_diagnostika_i_COVID-19_na_sayt_24.04.2020.pdf
15. Vremennye metodicheskie rekomendatsii profilaktika, diagnostika i lechenie novoy koronavirusnoy infektsii (COVID-19). Versiya 10 (08.02.2021) [Interim guidelines for the prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 10 (02/08/2021)], available at: https://static0.minzdrav.gov.ru/system/attachments/attaches/000/054/588/original/Vremennye_MR_COVID-19_%28v.10%29-08.02.2021_%281%29.pdf
16. Koronavirusnaya bolezn’ 2019 (COVID-19) i immunovospalitel’nye (autoimmunnye) revmaticheskie zabolevaniya. Proekt rekomendatsiy Obshcherossiyskoy obshchestvennoy organizatsii «Assotsiatsiya revmatologov Rossii» Nasonov E.L., Lila A.M., Mazurov V.I., Belov B.S., Karateev A.E., Dubinina T.V., Nikitinskaya O.A. po porucheniyu prezidiuma Obshcherossiyskoy obshchestvennoy organizatsii «Assotsiatsiya revmatologov Rossii» [Coronavirus disease 2019 (COVID-19) and immune-inflammatory (autoimmune) rheumatic diseases. Draft recommendations of the All-Russian public organization «Association of Rheumatologists of Russia» Nasonov E.L., Lila A.M., Mazurov V.I., Belov B.S., Karateev A.E., Dubinina T.V., Nikitinskaya O.A. … on behalf of the Presidium of the All-Russian Public Organization «Association of Rheumatologists of Russia»], available at: https://rheumatolog.su/news/koronavirusnaya-bolezn-2019-COVID-19-i-immunovospalitelnye-autoimmunnye-revmaticheskie-zabolevaniya